Read + Share
Jin H, Zhu Y, Hong M, Wu Y, et al. Co-occurrence of KIT and NRAS mutations defines an adverse prognostic
core-binding factor acute myeloid leukemia. Leuk Lymphoma 2021 May 24:1-10. doi: 10.1080/10428194.2021.1919660.
PMID: 34024223
|
 |
|
Jin H, Zhu Y, Hong M, Wu Y, et al. Co-occurrence of KIT and NRAS mutations defines an adverse prognostic
core-binding factor acute myeloid leukemia. Leuk Lymphoma 2021 May 24:1-10. doi: 10.1080/10428194.2021.1919660.
PMID: 34024223
|
|
|
|